Top Stories
The expanded label makes xT CDx the first US-approved test for both tumour-only and tumour-normal genomic profiling.
The smart ring maker added blood pressure signals, health records, GLP-1 tracking and access to licensed providers inside the Oura App.
The company reported that patients identified as Onclara IO High had a median overall survival of 484 days, compared with 155 days for those with 'low' designation.
Libre Duo and Libre Duo 10 Day monitor glucose and ketone levels every minute to detect changes that could lead to diabetic ketoacidosis.
The open discovery engine for protein structure prediction, design, and biological discovery is built around three releases: ESMC, ESMFold2 and ESM Atlas.
Conference News
Los Angeles -- A first-in-class PET imaging approach can accurately detect a biomarker for chronic traumatic encephalopathy (CTE), a devastating neurodegenerative disease associated with repeated head...
Findings published in npj Precision Oncology and presented at ASCO 2026 by Aqtual and UHN’s Princess Margaret Cancer Centre demonstrate longitudinal blood-based monitoring of tumor microenvironment bi...
Poor outcomes evident in patients with bone-only metastasesSociety of Nuclear Medicine and Molecular ImagingLos Angeles -- Compared to conventional imaging techniques, prostate specific membrane antig...
Society of Nuclear Medicine and Molecular ImagingLos Angeles -- A novel PET imaging approach enables simultaneous visualization of tumor progression and cardiac inflammatory responses during cancer tr...
Penn Medicine study offers actionable insights to improve the quality of patient resources on AI and cancer careReports and ProceedingsUniversity of Pennsylvania School of MedicineCHICAGO – Online inf...
